President Trump's plan to lower prescription drug prices hit two major obstacles this week. He killed a proposal on Wednesday that would have reduced out-of-pocket costs for older consumers out of concern that it would raise premiums heading into his re-election campaign. And a federal judge threw out a new requirement that drug companies disclose their prices in television ads.
Administration officials rushed to assure the public that the double setback did not reflect failure on one of the president's signature issues, one that has fueled public outrage and drawn the attention of both parties.
